1. Home
  2. RNXT vs PETS Comparison

RNXT vs PETS Comparison

Compare RNXT & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.83

Market Cap

37.4M

Sector

Health Care

ML Signal

HOLD

Logo PetMed Express Inc.

PETS

PetMed Express Inc.

HOLD

Current Price

$2.66

Market Cap

61.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNXT
PETS
Founded
2012
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Drug Stores and Proprietary Stores
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
37.4M
61.6M
IPO Year
2021
2003

Fundamental Metrics

Financial Performance
Metric
RNXT
PETS
Price
$0.83
$2.66
Analyst Decision
Strong Buy
Sell
Analyst Count
2
1
Target Price
$8.00
$3.20
AVG Volume (30 Days)
158.7K
141.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
59.60
18.92
EPS
N/A
N/A
Revenue
$43,000.00
$273,800,000.00
Revenue This Year
$2,995.35
N/A
Revenue Next Year
$219.61
$2.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$1.57
52 Week High
$1.45
$4.32

Technical Indicators

Market Signals
Indicator
RNXT
PETS
Relative Strength Index (RSI) 37.19 34.73
Support Level $0.82 $2.61
Resistance Level $1.07 $2.93
Average True Range (ATR) 0.06 0.15
MACD -0.01 -0.03
Stochastic Oscillator 9.48 10.42

Price Performance

Historical Comparison
RNXT
PETS

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Share on Social Networks: